Treatment of paroxysmal nonkinesigenic dyskinesia

Medicine and Dentistry

• Autosomal Dominant Inheritance 50%
• Benzatropine 50%
• Carbamazepine 50%
• Chromosome 2q 50%
• Clonazepam 50%
• Cohort Effect 50%
• Combination Therapy 50%
• Deep Brain Stimulation 50%
• Dyskinesia 100%
• Gene Mutation 50%
• Involuntary Movement 50%
• Loss of Consciousness 50%
• Stereotypic Movement Disorder 50%

Neuroscience

• Carbamazepine 50%
• Chromosome 2q 50%
• Clonazepam 50%
• Deep Brain Stimulation 50%
• Dyskinesia 100%
• Gene Mutation 50%
• Stereotypic Movement Disorder 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Benzatropine 50%
• Carbamazepine 50%
• Clonazepam 50%
• Combination Therapy 50%
• Dyskinesia 100%
• Motor Dysfunction 50%